AlphaCentric Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,500
Closed -$566K 285
2025
Q4
$566K Buy
+12,500
New +$457K 0.56% 57
2024
Q1
Sell
-20,000
Closed -$753K 246
2023
Q4
$753K Buy
20,000
+5,000
+33% +$184K 0.51% 62
2023
Q3
$676K Hold
15,000
0.38% 78
2023
Q2
$1.11M Hold
15,000
0.61% 60
2023
Q1
$880K Hold
15,000
0.61% 60
2022
Q4
$756K Buy
15,000
+5,000
+50% +$300K 0.75% 48
2022
Q3
$870K Buy
+10,000
New +$1.05M 0.89% 33
2021
Q4
$1.8M Hold
10,000
0.53% 8
2021
Q3
$1.48M Hold
10,000
0.38% 13
2021
Q2
$1.51M Hold
10,000
0.41% 9
2021
Q1
$1.3M Sell
10,000
-5,000
-33% -$641K 0.44% 12
2020
Q4
$1.8M Hold
15,000
0.75% 5
2020
Q3
$1.12M Hold
15,000
0.54% 7
2020
Q2
$1.06M Buy
+15,000
New +$1.03M 0.6% 9

Other funds holding OMCL

AlphaCentric Advisors's OMCL Position: Q1 2026 in Review

AlphaCentric Advisors sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 12,500 shares — an estimated $566K sold.

AlphaCentric Advisors first reported a position in OMCL in Q2 2020 and held it in 14 quarters. The position peaked at $1.8M in Q4 2021. 273 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • AlphaCentric Advisors reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
  • AlphaCentric Advisors sold 12,500 Omnicell shares in Q1 2026, an estimated $566K.
  • AlphaCentric Advisors first reported a position in Omnicell in Q2 2020 and held it in 14 quarters.
  • AlphaCentric Advisors's Omnicell position peaked at $1.8M in Q4 2021.
  • 273 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.